Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

WX-UK1 cleared for phase I trials in the U.S.

May 23, 2003

Phase II trial planned for GTI-2501 in metastatic prostate cancer

May 23, 2003

Triapine in new phase II trial with gemcitabine for NSCLC

May 23, 2003

FDA approves Gleevec for Ph+ CML

May 23, 2003

Data safety monitoring board clears phase III Thymitaq trial to continue

May 23, 2003

PI3-kinase modulators with antiproliferative activity reported by Iconix

May 23, 2003

Millennium ships Velcade within a week of FDA approval

May 22, 2003

Kirin identifies new antitumor FGFR inhibitors

May 22, 2003

Sankyo describes new compounds with PPARgamma-agonist and antitumor activity

May 22, 2003

Water-soluble etoposide prodrugs prepared and tested by French research team

May 22, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...